Cureus | Probing the Increased Virulence of Severe Acute Respiratory Syndrome Coronavirus 2 B.1.617 (Indian Variant) From Predicted Spike Protein Structure | Article
gb SARS-CoV-2 Variant E484K, L452R - Generi Biotech
Emergence of SARS-CoV-2 lineage A.27 in Germany, expressing viral spike proteins with several amino acid replacements of interest, including L18F, L452R, and N501Y in the absence of D614G - nCoV-2019 Genomic Epidemiology -
SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity
Recombinant SARS-CoV-2 L452R Spike RBD His-tag Protein, CF 10787-CV-100: R&D Systems
Virus explainer: A look at the variant showing up in the Bay Area
-1.jpg "New research examines the elimination of the B.1.362 + L452R variant in Israel")
New research examines the elimination of the B.1.362 + L452R variant in Israel
Virus explainer: A look at the variant showing up in the Bay Area
Transmission, infectivity, and antibody neutralization of an emerging SARS-CoV-2 variant in California carrying a L452R spike protein mutation | medRxiv
SARS-CoV-2 spike L452R mutation increases Omicron variant fusogenicity and infectivity as well as host glycolysis | Signal Transduction and Targeted Therapy
L452R mutation potentially favors adaptive evolution of SARS-CoV-2
Microorganisms | Free Full-Text | SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra, India
Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant - ScienceDirect
SARS-CoV-2 variants containing L452R spike mutation more resistant to antibody-mediated neutralization
Virus explainer: A look at the variant showing up in the Bay Area
L452R mutation a key player in the evolution of SARS-CoV-2
Convergent evolution of SARS-CoV-2 spike mutations, L452R, E484Q and P681R, in the second wave of COVID-19 in Maharashtra, India | bioRxiv
Virus explainer: A look at the variant showing up in the Bay Area
The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity
